NEW YORK, June 29, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inari Medical, Inc. (NASDAQ: NARI) between February 24, 2022 and February 28, 2024, both dates inclusive (the “Class Period”), of the important July 12, 2024 lead plaintiff deadline. SO WHAT: If you purchased Inari Medical common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee ...